Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Einar S Björnsson, Ottar M Bergmann, Helgi K Björnsson...
https://pubmed.ncbi.nlm.nih.gov/23419359/Actively Recruiting
Led by University of Nottingham · Updated on 2026-07-27
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research focuses on idiosyncratic drug-induced liver injury DILI, an unpredictable liver reaction to medications taken at normal doses. DILI is a significant cause of itching pruritus in adults, second only to biliary obstruction, especially in cholestatic or mixed types where bile flow is impaired. The study aims to better understand how often itching occurs in DILI and its effects on patients quality of life, establishing a network of centers for future treatment trials. Participants diagnosed with suspected acute DILI based on specific liver enzyme levels will be observed. The study monitors the incidence, duration, and severity of itching in these patients over several years, along with genetic factors linked to itching. The study does not involve experimental treatments but collects detailed data to inform future therapeutic approaches. During the study, participants will undergo clinical evaluations including liver function tests within 36 hours of enrollment. Patient-reported health status and quality of life will be assessed over a follow-up period of up to four years. Researchers aim to gather comprehensive information on the natural history of itching in DILI, including genetic influences and symptom progression, to support the development of new treatments and improve patient care.
CONDITIONS
Drug-induced Liver Injury: Itching Study
E
Elinor Study Coordinator
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Nottingham
Lead Sponsor
Ipsen
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 4 years
Participants are observed over time to track the occurrence, duration, and severity of itching related to drug-induced liver injury. Clinical tests and patient questionnaires are used to assess health status and symptoms.
Regular follow-up visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Einar S Björnsson, Ottar M Bergmann, Helgi K Björnsson...
https://pubmed.ncbi.nlm.nih.gov/23419359/G P Aithal, P B Watkins, R J Andrade...
https://pubmed.ncbi.nlm.nih.gov/21544079/Huey-Ling Chen, Huei-Ying Li, Jia-Feng Wu...
https://pubmed.ncbi.nlm.nih.gov/30366773/Raul J Andrade, Naga Chalasani, Einar S Björnsson...
https://pubmed.ncbi.nlm.nih.gov/31439850/European Association for the Study of the Liver
https://pubmed.ncbi.nlm.nih.gov/30926241/Robert J Fontana, Paul H Hayashi, Huiman Barnhart...
https://pubmed.ncbi.nlm.nih.gov/26346867/Einar S Björnsson, Camilla Stephens, Edmond Atallah...
https://pubmed.ncbi.nlm.nih.gov/35899490/University of Nottingham
Lead Sponsor
Ipsen
Collaborating Sponsor